en Experimental Neurobiology

Cited by CrossRef (6)

  1. Caroline Ruetsch-Chelli, Saskia Bresch, Barbara Seitz-Polski, Alessandra Rosenthal, Claude Desnuelle, Mikael Cohen, Vesna Brglez, Michel Ticchioni, Christine Lebrun-Frenay. Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis. Neurotherapeutics 2021;18:938
    https://doi.org/10.1007/s13311-021-01006-9
  2. Supriya Ramesha, Sruti Rayaprolu, Christine A. Bowen, Cynthia R. Giver, Sara Bitarafan, Hai M. Nguyen, Tianwen Gao, Michael J. Chen, Ngozi Nwabueze, Eric B. Dammer, Amanda K. Engstrom, Hailian Xiao, Andrea Pennati, Nicholas T. Seyfried, David J. Katz, Jacques Galipeau, Heike Wulff, Edmund K. Waller, Levi B. Wood, Allan I. Levey, Srikant Rangaraju. Unique molecular characteristics and microglial origin of Kv1.3 channel–positive brain myeloid cells in Alzheimer’s disease. Proc. Natl. Acad. Sci. U.S.A. 2021;118
    https://doi.org/10.1073/pnas.2013545118
  3. Zinovia-Maria Kefalopoulou, Dimitra Veltsista, Alexandra Germeni, Dimosthenis Lykouras, Eirini Tsiamaki, Elisabeth Chroni. Rituximab as a sole steroid-sparing agent in generalized myasthenia gravis: Long-term outcomes. Neurol Sci 2024;45:1233
    https://doi.org/10.1007/s10072-023-07082-3
  4. Yuzi Li, Zhanguo Li, Fanlei Hu. Double-negative (DN) B cells: an under-recognized effector memory B cell subset in autoimmunity. 2021;205:119
    https://doi.org/10.1111/cei.13615
  5. A Uzawa, S Kuwabara, S Suzuki, T Imai, H Murai, Y Ozawa, M Yasuda, Y Nagane, K Utsugisawa. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. 2021;203:366
    https://doi.org/10.1111/cei.13546
  6. Zhuo Zhang, Xin Xie, Ying Cai, Peipei Liu, Shoufeng Liu, Rongjie Chen, Jin Wang, Yue Wang, Yanan Zhao, Zhizhong Zhu, Xinyuan Zhang, Jialing Wu. Abnormal immune function of B lymphocyte in peripheral blood of Parkinson's disease. Parkinsonism & Related Disorders 2023;116:105890
    https://doi.org/10.1016/j.parkreldis.2023.105890